Learn how NK cell therapy is a powerful alternative to CAR-T therapies for multiple myeloma, targeting B-cell maturation with ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations & Market Opportunity Insight 2025" has been added to ...

Research and development activities for NK cell therapies are rapidly evolving, backed by significant advancements in immunotherapy-centric cancer treatment approaches. Unlike other immune cells, NK ...

A year ago, Caribou Biotherapeutics’ CEO was telling Fierce Biotech that the company’s natural killer (NK) cell therapy program was the “tip of the spear” for its solid tumor strategy and didn't hint ...

Background Sympathetic signalling plays a critical role in the initiation and progression of various malignancies. However, ...

In the battlefield of modern medicine, breakthroughs often arrive as new drugs or high-tech procedures. Yet a quieter revolution is underway, one that draws its strength from the body's own defences ...

Weill Cornell Medicine researchers have identified that Hodgkin lymphoma cells are immune cells trapped midway between B cell and plasma cell development, unable to produce antibodies. This ...

Fill out the form below and we'll send your colleague an invitation to the "Advancing Gene Editing for Next-Generation Immune Cell Therapies" event. Natural killer (NK) cells are emerging as a ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that new preclinical data for its proprietary SPiKE platform has been accepted ...